VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Canada

Ottawa Hospital Research Institute, Ottawa, Ontario